"... The settlement, reached in February 2012 to resolve dozens of suits over Monsanto’s disposal of dioxin waste at a now-defunct facility in Nitro, W.Va., includes a $21 million fund that will pay for the medical testing of eligible Nitro community class members, which include thousands of people who lived, worked or attended school in the Nitro area during the period covered by the suit. ..."
Law360, New York (January 27, 2014, 5:37 PM ET) -- Objectors to Monsanto Co.'s $93 million deal with West Virginia residents alleging medical harm and property damage from Agent Orange herbicide produced at a nearby plant have turned to the U.S. Supreme Court after the state high court rejected their intraclass conflict claims.
Three courts, including the West Virginia Supreme Court, have already declined to question the scope of the deal’s benefit allocations, which involve threshold levels of exposure that the objectors claim will leave 75,000 out of 80,000 class members uncompensated for medical monitoring, while only 40 percent will qualify for property damage payments.In upholding the settlement in November, the state high court rejected claims that the settlement created separate subclasses of those who will benefit and those who will not, saying the fact that some class members stood to receive nothing did not indicate a fundamental intraclass conflict.
But the decision contradicted instructions from the Supreme Court in its 1997 Anchem Products Inc. v. Windsor decision and elsewhere that subgroups with adverse interests cannot be bound by common counsel to an unfavorable settlement, according to the objectors’ Jan. 21 petition for writ of certiorari.
The settlement, reached in February 2012 to resolve dozens of suits over Monsanto’s disposal of dioxin waste at a now-defunct facility in Nitro, W.Va., includes a $21 million fund that will pay for the medical testing of eligible Nitro community class members, which include thousands of people who lived, worked or attended school in the Nitro area during the period covered by the suit.
On top of that fund, up to $63 million in additional funding will be available over the course of the 30-year medical-monitoring program, while a separate, $9 million fund will be put toward professional cleaning of about 4,500 eligible homes out of 12,000 in total within a five-mile radius of the plant, court records show. Monsanto also agreed to make a separate $29.5 million payment in attorneys' fees and costs.
The lower courts all found the settlement permissible because all claimants were subjected to the same qualifying criteria for receiving payments. In their petition, the five petitioners led by Virdie Allen argued that the settlement was only evaluated for fairness, while their arguments regarding intraclass conflicts were given short shrift.
The conflict was triggered when it became clear that a “distinct subclass” of both the medical and property classes would receive no benefits “based on an arbitrary line” drawn between class counsel and Monsanto, the petition said.
The petition also took issue with the trial court’s decision to recertify the property class for settlement purposes after having decertified it due to concerns over expert witness methodology, saying that under class certification guidelines the adequacy of the settlement class, including its representation, required a fresh take once the deal was struck.
A parallel lawsuit has been proceeding since 2009 in New York federal court and in 2011 survived a partial summary judgment bid based on Monsanto's attempt to dodge liability under its status as a government contractor. Court records filed in early January indicate that the case has settled but that any deal is contingent on final approval of the West Virginia case.
The petitioners are represented by Thomas F. Urban II of the Law Firm of Urban & Falk PLLC.
The case is Virdie Allen et al. v. Monsanto Co. et al., case number 13-887, in the U.S. Supreme Court.
--Additional reporting by Sean McLernon and Maria Chutchian. Editing by Elizabeth Bowen.
W.Va. High Court Upholds $93M Monsanto Agent Orange Deal
Monsanto Agent Orange Suits End In Medical Monitoring Deal
Tort Claimants Object To Solutia, Monsanto Pact
Dairy Farmer Subclass Gets Recertified In Antitrust MDL
5th Circ. Sets Arbitration Rules In Conoco Win Over Union
Chevron Wants Del. High Court's Final Stamp On Forum Bylaw
Texas Court Trims Cop's Defamation Suit Against Union
High Court Urged To Review Medical Whistleblower Protection
9th Circ. Hands Win To Ecuador In Chevron Discovery Fight